Efficacy and Safety of Romosozumab Treatment in Postmenopausal Women With Osteoporosis

NCT01575834 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

7180

Enrollment

INDUSTRY

Sponsor class

Conditions

Postmenopausal Osteoporosis

Interventions

DRUG: Romosozumab
DRUG: Placebo
DRUG: Denosumab

Sponsor

Amgen